Deutsche Bank Initiates Coverage On National Health Investors with Buy Rating, Announces Price Target of $69
Portfolio Pulse from Benzinga Newsdesk
Deutsche Bank analyst Omotayo Okusanya has initiated coverage on National Health Investors (NYSE:NHI) with a Buy rating and set a price target of $69.
January 30, 2024 | 12:12 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Deutsche Bank has initiated coverage on National Health Investors with a Buy rating and a price target of $69.
The initiation of coverage by Deutsche Bank with a Buy rating typically indicates a positive outlook on the stock, suggesting that the bank believes NHI will perform well in the near term. The price target of $69 implies a potential upside from the current trading price, which can lead to increased investor interest and a possible rise in the stock price.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100